Literature DB >> 10369110

The influence of radiation and chemotherapy-related DNA strand breaks on carcinogenesis: an evaluation.

J J Froelich1, F R Schneller, R K Zahn.   

Abstract

PURPOSE: DNA strand breaks are believed to induce carcinogenesis. This study was conducted to analyze induction and repair of irradiation- and chemotherapy-related strand breaks in vitro.
METHODS: Friend Leukemia cells were exposed to irradiation and various chemotherapeutic agents at different doses and concentrations. Occurrence of strand breaks was determined fluorometrically, measuring the rate of DNA unwinding immediately after exposure and 24 hours later.
RESULTS: The amount of double-stranded DNA decreased significantly for irradiation, doxorubicin, dactinomycin and etoposide (p < or = 0.05, t-test). After 24 hours free of exposure, the persistent damage was detectable for all of these agents but not for irradiated cells, with DNA strand breaks being decreased for etoposide, unchanged for doxorubicin and increased for methotrexate as well as for dactinomycin.
CONCLUSIONS: Severe DNA damage is induced by various chemotherapeutic agents and by irradiation. While repair of chemotherapy-related strand breaks may remain incomplete or prolonged for some chemotherapeutic agents, repair of radiation induced strand breaks is faster and more complete. Therefore chemotherapy-related carcinogenesis may partially be explained by prolonged persistence of DNA strand breaks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369110     DOI: 10.1515/CCLM.1999.066

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  3 in total

1.  Parameiosis in Aspergillus nidulans in response to doxorubicin.

Authors:  T C A Becker; M A A De Castro-Prado
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 2.  Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature.

Authors:  Jaclyn Frances Hechtman; Ronald DeMatteo; Khedoudja Nafa; Ping Chi; Maria E Arcila; Snjezana Dogan; Alifya Oultache; Wen Chen; Meera Hameed
Journal:  Ann Surg Oncol       Date:  2015-01-07       Impact factor: 5.344

3.  Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.